文献速递慢性静脉疾病

揭示静脉性溃疡疼痛与细菌负荷的关系及其对靶向治疗的启示

Unveiling the relationship between pain and bacterial load in venous ulcers with implications in targeted treatment.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2025-02-19

研究纳入46例疼痛评分≥4分的下肢静脉性溃疡患者,在清创前进行荧光成像检测细菌负荷,比较疼痛区域与荧光信号的区域重叠,并评估清创后疼痛变化。结果显示荧光信号与疼痛区域常有重叠,清创后平均疼痛评分从8.17降至6.87(降低1.30分,P<.0001),清创后1天复评降低3.40分(P=.004)。

要点

  • 静脉性溃疡中临床显著细菌负荷的荧光信号普遍存在,常覆盖≤50%创面并多定植于创缘。
  • 46例中40例(87%)疼痛区域与荧光信号存在重叠,29例重叠>25%,16例重叠>50%。
  • 靶向细菌清除后疼痛评分平均降低1.30分(P<.0001),清创后1天复评降低3.40分(P=.004)。

核心结论

  • 静脉性下肢溃疡中临床显著细菌定植和生物膜的荧光信号常见,患者报告的疼痛区域与阳性荧光常重叠,提示两者存在关系。
  • 通过实时荧光成像客观靶向清除细菌后,伤口相关疼痛评分显著且立即降低,次日复评降低幅度更大。
  • 理解静脉性溃疡中慢性细菌存在与疼痛的关联可为治疗和管理策略提供信息,可能改善患者生活质量和满意度、促进愈合及减少并发症。

研究设计与样本

  • 研究评估46例自我报告伤口相关疼痛评分≥4分(1至10分量表)的下肢静脉性溃疡成人患者。
  • 在任何治疗(如清创)前,患者评定研究访视期间的疼痛并采集荧光图像,将疼痛区域和阳性荧光信号区域勾画在打印的伤口图像上。
  • 操作后重复荧光成像,患者在访视结束时或次日通过电话重新评定疼痛。
  • 采用半定量分析,通过视觉估计创床中荧光区域与疼痛区域的百分比重叠。
  • 使用Wilcoxon配对符号秩检验和Mann-Whitney t检验评估操作后疼痛评分变化。

主要发现

  • 所有评估的静脉性溃疡均存在提示细菌负荷升高和生物膜的荧光,通常覆盖≤50%的创面,并常见定植于创缘。
  • 创床内疼痛区域比荧光区域更广泛,46例中40例(87%)存在一定程度重叠;29例重叠>25%,16例重叠>50%。
  • 操作前总体平均疼痛评分为8.17,操作后为6.87,对应降低1.30分,具有高度统计学显著性(P<.0001)。
  • 清创后1天重新评定疼痛时,疼痛评分降低幅度更高(降低3.40分;P=.004)。

临床怎么用

  • 作者认为,理解静脉性溃疡中慢性细菌存在与疼痛的关联可为治疗和管理策略提供信息,可能改善患者生活质量和满意度、促进愈合及减少并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The relationship between bacteria and venous ulceration pain is well-established and primarily attributable to inflammatory pathways. Fluorescence imaging detects clinically significant bacterial loads and biofilm in real time at the bedside, informing its elimination in an objective manner. We sought to explore the regional co-localization of bacterial fluorescence signals and patient-reported venous ulceration pain, and if objectively targeted bacterial removal can reduce wound-associated pain. METHODS: We evaluated 46 adults with venous ulceration of the lower extremity self-reporting a wound-associated pain score of ≥4 on a scale of 1 to 10. Before any treatments were performed (eg, debridement), patients rated their pain during the study visit, and fluorescence images were captured. Regions of pain and positive fluorescence signals were sketched onto a printed wound image. Fluorescence imaging was repeated post procedurally, and patients rerated their pain either at the end of the study visit or over the phone the following day. Semiquantitative analysis involved visual estimation of the percentage overlap between regions of fluorescence and pain in the wound bed. Wilcoxon matched pairs signed rank tests and Mann-Whitney t tests assessed changes in pain scores post procedurally. RESULTS: Fluorescence from elevated bacterial loads and biofilm was present in every venous ulcer assessed, usually covering ≤50% of the wound bed and commonly colonizing the wound edges. Regions of pain were more extensive than regions of fluorescence within the wound bed, and some degree of overlap was identified in 40 of 46 patients (87%). This overlap was often substantial (29 patients with >25% overlap and 16 with >50% overlap). Overall mean pain scores were 8.17 before the procedure and 6.87 after the procedure, corresponding with a 1.30-point reduction that was highly statistically significant (P < .0001). Pain score reduction was higher when patients rerated their pain 1 day after debridement (3.40-point reduction; P = .004). CONCLUSIONS: We observed that fluorescence signals from clinically significant bacterial colonization and biofilms were commonly present in painful venous lower extremity ulcerations. Regions of patient-reported pain and positive fluorescence frequently overlapped, suggesting a relationship between the two. Wound-associated pain scores were significantly and immediately reduced after objectively targeted bacterial removal via real-time fluorescence imaging, with an even greater reduction observed by the next day. Understanding the association between chronic bacterial presence and pain in venous ulcers can inform treatment and management strategies, potentially enhancing patient quality of life and satisfaction, promoting healing, and reducing complications.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Oropallo AR, Lee PJ, Rao A, et al. Unveiling the relationship between pain and bacterial load in venous ulcers with implications in targeted treatment. J Vasc Surg Venous Lymphat Disord. 2025. PMID: 39983865. doi:10.1016/j.jvsv.2025.102213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。